← Back to headlines
Eli Lilly Nears $2 Billion Deal for Kelonia to Expand Cancer Pipeline
Pharmaceutical giant Eli Lilly is reportedly close to acquiring Kelonia Therapeutics in a deal valued at over $2 billion, aiming to bolster its cancer treatment pipeline.
19 Apr, 22:08 — 19 Apr, 22:08
Sources
Showing 1 of 1 sources
